AstraZeneca gets FDA breakthrough status for Farxiga in CKD
AstraZeneca has been granted breakthrough therapy designation (BTD) for Farxiga (dapagliflozin) from the US Food and Drug Administration (FDA) for the treatment of patients with chronic kidney disease (CKD), irrespective of type 2 diabetes (T2D). According to the US Centers for Disease Control and Prevention (CDC), chronic kidney disease is a serious, progressive condition defined […]
Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine injection) in vial and pre-filled pen presentations to regulate high blood sugar in adults with type 2 diabetes and adult and pediatric patients with type 1 diabetes. According to Mylan, Semglee has an identical amino acid sequence […]
Continue reading …Lilly bags Trulicity FDA approval for reducing CV risk in type 2 diabetes patients
February 22, 2020 No Comment
Trulicity FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug Administration (FDA) for Trulicity (dulaglutide) to reduce major cardiovascular events (MACE) in type 2 diabetes patients having established cardiovascular (CV) disease or multiple cardiovascular risk factors. The latest FDA approval Trulicity means that the drug the first […]
Continue reading …
Rybelsus FDA approval : Danish pharma company Novo Nordisk has bagged approval from the US Food and Drug Administration (FDA) for Rybelsus (semaglutide) oral tablets for its use in patients with type 2 diabetes. The FDA approval for Rybelsus is to improve control of blood sugar in addition to diet and exercise in adults having […]
Continue reading …Boehringer Ingelheim to initiate phase 2 trial of BI 456906 in obesity, diabetes
September 3, 2019 No Comment
German drugmaker Boehringer Ingelheim will initiate Phase 2 clinical trial of dual-acting GLP-1/glucagon agonist BI 456906 in obesity and diabetes in late 2019. The compound in-licensed from Zealand Pharma is derived from the natural gut hormone oxyntomodulin and activates both the GLP-1 and glucagon receptors to control metabolic activities. The dual agonist BI 456906 with […]
Continue reading …
In a report from Daily Mail, it is reported that a compound present in Broccoli extract can become a secret cure for diabetes for controlling blood sugar levels in diabetic patients. If diabetic patients consume broccoli in the form of juice, it can help stop type 2 diabetes. The existing drug treatments are having issues […]
Continue reading …
As per the research done by a group of scientists, it was revealed that drinking fruit juices could increase the risk of developing Type 2 Diabetes. Fruit juices contains high sugar and lack fibre content which may increase the risk of developing diabetes. Scientist warned that diabetic patients should not replace high-sugar beverages with fruit […]
Continue reading …
Danish pharma firm Novo Nordisk has secured the approval from the U.S. Food and Drug Administration (FDA) for using its diabetes drug Victoza (liraglutide) to treat heart diseases associated with type 2 diabetes. The Novo Nordisk diabetes drug Victoza can now be used in the US to decrease the risk of major adverse cardiovascular (CV) […]
Continue reading …
Business News Today
- Lendesk acquires digital mortgage origination provider Finmo Financial
- B&G Foods to acquire Crisco shortening brand from Smucker’s for $550m
- Carlyle Group acquires 27 distribution logistics assets in France and Germany
- LubeZone acquires mobile truck services provider All Star Truck Repair
- Diageo to acquire Chase Original Potato Vodka owner Chase Distillery
- Coca-Cola European Partners plans to acquire Coca-Cola Amatil for $6.6bn
- Verisem acquires new vegetable seed processing facility in Warden, WA
- GrubMarket acquires Los Angeles-based produce provider Best Fresh Produce
- Danone’s Nutricia acquires special needs business Real Food Blends
- Bluestar Alliance wins stalking horse bid for tween fashion brand Justice
